Treatment Updates for mCRC

 

ASCO 2022 Conference Coverage
C

ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment for Unresectable RAS and BRAF Wild-Type mCRC: Results of the Phase III Randomized TRIPLETE Study by GONO

By ASCO 2022 Conference Coverage FEATURING Chiara Cremolini
By ASCO 2022 Conference Coverage FEATURING Chiara Cremolini
185 views
June 10, 2022
0 Comments
Login to view comments. Click here to Login
Treatment Updates for mCRC
15:07
UCSF School of Medicine

Impact of Primary Tumor Location on OS and PFS in Patients with mCRC…

Feat. A. Venook
16:00
ecancer

Tumor Agnostic Treatments in GI Cancers: Liquid Bipsy, Biomarkers

Feat. N. Normanno, K. Schmitz
11:42
Penn Medicine Abramson Cancer Center

Penn Medicine Updates on the Role of Systemic Therapy in CRC Liver M…

Feat. T. Karasic
30:15
Houston Methodist Hospital

Role of Systemic Therapy in Colorectal Cancer

Feat. M. O. Khalil
27:45
CECOG Academy

Adjuvant Treatment of Colon Cancer: Duration of Treatment and Patien…

Feat. G. Prager
41:57
2022 Community Oncology Conference

The Colorectal Cancer Epidemic: Root Causes & Remedies

Feat. R. Goldberg
09:32
Michael Hummel

BRAF Testing in Metastatic Colorectal Carcinoma and Novel, Chemother…

11:34
ASCO 2022 Conference Coverage

ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as Initial Treatment …

Feat. C. Cremolini
34
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 on mFOLFOXIRI + PAN vs. mFOLFOX6/PAN as …

Feat. C. Cremolini
10:29
ASCO 2022 Conference Coverage

ASCO 2022 Using cfDNA to Identify Guideline-Relevant Biomarkers for …

Feat. P. Kasi
18:02
Nebraska Oncology Society

ASCO 2022 Updates on RAS/BRAF/KRAS/NRAS Wild-Type mCRC: Summary of R…

Feat. G. Kim
09:14
Nebraska Oncology Society

ASCO 2022 Updates on Colon Cancer Treatment

Feat. G. Kim
02:15
ASCO 2022 Conference Coverage

Lecture Summary - ASCO 2022 Adjuvant Chemotherapy Guided by ctDNA An…

Feat. J. Tie
07:56
ASCO 2022 Conference Coverage

ASCO 2022 on RAS Co-Mutation and Early Onset Disease Represent an Ag…

Feat. B. Johnson
13:16
ESMO 2022 Conference Coverage

ESMO 2022 on the NICHE-2 Study: Neoadjuvant Immune Checkpoint Inhibi…

Feat. M. Chalabi
29:47
Fortunato Ciardiello

Treatment Sequencing in mCRC

13:02
Yale Cancer Center

Personalized Treatment for Patients Living With mCRC

Feat. M. Cecchini